Polylactic Acid Membranes, a Novel Adjunct Treatment for Bullous Impetigo

Impetigo is a highly contagious bacterial skin infection characterized by blistering and erosions that can lead to significant discomfort and complications. The standard treatment includes topical or systemic antibiotics, but severe cases may require advanced wound management strategies. Polylactic...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Lorena Novoa-Moreno, Mario Aurelio Martinez-Jimenez, Arturo Ortiz-Alvarez, Natalia Sanchez-Olivo, Victor Manuel Loza-Gonzalez, Jose Luis Ramirez-GarciaLuna
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Infectious Disease Reports
Subjects:
Online Access:https://www.mdpi.com/2036-7449/17/3/72
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849471906125709312
author Ana Lorena Novoa-Moreno
Mario Aurelio Martinez-Jimenez
Arturo Ortiz-Alvarez
Natalia Sanchez-Olivo
Victor Manuel Loza-Gonzalez
Jose Luis Ramirez-GarciaLuna
author_facet Ana Lorena Novoa-Moreno
Mario Aurelio Martinez-Jimenez
Arturo Ortiz-Alvarez
Natalia Sanchez-Olivo
Victor Manuel Loza-Gonzalez
Jose Luis Ramirez-GarciaLuna
author_sort Ana Lorena Novoa-Moreno
collection DOAJ
description Impetigo is a highly contagious bacterial skin infection characterized by blistering and erosions that can lead to significant discomfort and complications. The standard treatment includes topical or systemic antibiotics, but severe cases may require advanced wound management strategies. Polylactic acid (PLA)-based membranes have demonstrated effectiveness in enhancing wound healing, modulating inflammation, and reducing pain. <b>Clinical case:</b> We present three cases of bullous impetigo with extensive erosions, managed using PLA membranes as an adjunct to systemic antibiotics. A significant improvement was shown after 7 days of treatment of a single application, and complete resolution was achieved after 30 days. Notably, pain was resolved within 48–72 h, highlighting the analgesic and protective properties of the membrane. <b>Conclusions:</b> These findings suggest that PLA membranes provide a viable adjunct to antibiotic therapy in bullous impetigo, accelerating healing, reducing discomfort, and improving long-term skin outcomes. Given the increasing concern over antibiotic resistance and the limitations of standard wound care, bioresorbable synthetic membranes represent a promising alternative in dermatological wound management.
format Article
id doaj-art-67c705dd8ce64c57bdbde06d19ac5494
institution Kabale University
issn 2036-7449
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Infectious Disease Reports
spelling doaj-art-67c705dd8ce64c57bdbde06d19ac54942025-08-20T03:24:40ZengMDPI AGInfectious Disease Reports2036-74492025-06-011737210.3390/idr17030072Polylactic Acid Membranes, a Novel Adjunct Treatment for Bullous ImpetigoAna Lorena Novoa-Moreno0Mario Aurelio Martinez-Jimenez1Arturo Ortiz-Alvarez2Natalia Sanchez-Olivo3Victor Manuel Loza-Gonzalez4Jose Luis Ramirez-GarciaLuna5Wound Clinic of the Regional High-Specialty Hospital “Ignacio Morones Prieto”, San Luis Potosí 78220, SLP, MexicoWound Clinic of the Regional High-Specialty Hospital “Ignacio Morones Prieto”, San Luis Potosí 78220, SLP, MexicoInfectology Department of the Regional High-Specialty Hospital “Ignacio Morones Prieto”, San Luis Potosí 78220, SLP, MexicoWound Clinic of the Regional High-Specialty Hospital “Ignacio Morones Prieto”, San Luis Potosí 78220, SLP, MexicoWound Clinic of the Regional High-Specialty Hospital “Ignacio Morones Prieto”, San Luis Potosí 78220, SLP, MexicoWound Clinic of the Regional High-Specialty Hospital “Ignacio Morones Prieto”, San Luis Potosí 78220, SLP, MexicoImpetigo is a highly contagious bacterial skin infection characterized by blistering and erosions that can lead to significant discomfort and complications. The standard treatment includes topical or systemic antibiotics, but severe cases may require advanced wound management strategies. Polylactic acid (PLA)-based membranes have demonstrated effectiveness in enhancing wound healing, modulating inflammation, and reducing pain. <b>Clinical case:</b> We present three cases of bullous impetigo with extensive erosions, managed using PLA membranes as an adjunct to systemic antibiotics. A significant improvement was shown after 7 days of treatment of a single application, and complete resolution was achieved after 30 days. Notably, pain was resolved within 48–72 h, highlighting the analgesic and protective properties of the membrane. <b>Conclusions:</b> These findings suggest that PLA membranes provide a viable adjunct to antibiotic therapy in bullous impetigo, accelerating healing, reducing discomfort, and improving long-term skin outcomes. Given the increasing concern over antibiotic resistance and the limitations of standard wound care, bioresorbable synthetic membranes represent a promising alternative in dermatological wound management.https://www.mdpi.com/2036-7449/17/3/72skin infectionsimpetigopolylactic-acid-based biomaterialswound healinglocal anti-infective agents
spellingShingle Ana Lorena Novoa-Moreno
Mario Aurelio Martinez-Jimenez
Arturo Ortiz-Alvarez
Natalia Sanchez-Olivo
Victor Manuel Loza-Gonzalez
Jose Luis Ramirez-GarciaLuna
Polylactic Acid Membranes, a Novel Adjunct Treatment for Bullous Impetigo
Infectious Disease Reports
skin infections
impetigo
polylactic-acid-based biomaterials
wound healing
local anti-infective agents
title Polylactic Acid Membranes, a Novel Adjunct Treatment for Bullous Impetigo
title_full Polylactic Acid Membranes, a Novel Adjunct Treatment for Bullous Impetigo
title_fullStr Polylactic Acid Membranes, a Novel Adjunct Treatment for Bullous Impetigo
title_full_unstemmed Polylactic Acid Membranes, a Novel Adjunct Treatment for Bullous Impetigo
title_short Polylactic Acid Membranes, a Novel Adjunct Treatment for Bullous Impetigo
title_sort polylactic acid membranes a novel adjunct treatment for bullous impetigo
topic skin infections
impetigo
polylactic-acid-based biomaterials
wound healing
local anti-infective agents
url https://www.mdpi.com/2036-7449/17/3/72
work_keys_str_mv AT analorenanovoamoreno polylacticacidmembranesanoveladjuncttreatmentforbullousimpetigo
AT marioaureliomartinezjimenez polylacticacidmembranesanoveladjuncttreatmentforbullousimpetigo
AT arturoortizalvarez polylacticacidmembranesanoveladjuncttreatmentforbullousimpetigo
AT nataliasanchezolivo polylacticacidmembranesanoveladjuncttreatmentforbullousimpetigo
AT victormanuellozagonzalez polylacticacidmembranesanoveladjuncttreatmentforbullousimpetigo
AT joseluisramirezgarcialuna polylacticacidmembranesanoveladjuncttreatmentforbullousimpetigo